Assessment of Adherence to Treatment with Ethylmethylhydroxypyridine Malate in Patients with Chronic Cerebral Ischemia Using a Digital Platform

Background. The problem of adherence to medical recommendations is always relevant. Low or nonadherence treatment has negative clinical and economic effects, such as influence on success, prolongation disease duration, increased risk hospitalization, outcomes, mortality risk.
 aim this study was assess the impact using RX Observatory digital platform with Etoxydol (ethylmethylhydroxypyridine malate) in patients chronic cerebral ischemia (CCI). 
 Materials methods. Medication studied CCI who visited doctors three Moscow city polyclinics research questionnaires.
 Results. found that 47% fully adhered prescribed medication. Adherence higher if medication by a specialist (general practitioner – 36 %, neurologist 56 %), although among visiting general practitioners 48 43 %).
 Conclusions. showed may be useful tool for developing taking malate).